Month: September 2021

IV BioHoldings Debuts Liquid Biopsy Portfolio; Partners with P4 Diagnostix to Scale Commercialization of Non-Invasive Lung, Liver and Breast Diagnostics

Bio innovation studio behind liquid biopsy companies LiquidLung, HepGene, and Mammogen, comes out of stealth with eight clinical-ready diagnostics Formed...

Healthy Extracts Begins New Clinical Trial to Investigate Ability of UBN RELIEF™ to Naturally Alleviate Migraine Symptoms and Improve Cognitive Function

UBN RELIEF™ UBN RELIEF™ is clinically proven to provide some relief from symptoms often related to migraine headaches. LAS VEGAS,...

SCYNEXIS Announces U.S. Availability of BREXAFEMME® (ibrexafungerp tablets), the First New Antifungal Class of Therapy Approved by the U.S. FDA for Vaginal Yeast Infections in More Than 20 Years

BREXAFEMME® (ibrexafungerp tablets) Product Image #1 BREXAFEMME® (ibrexafungerp tablets) Package Image #2 BREXAFEMME® (ibrexafungerp tablets) Product Logo SCYNEXIS Logo SCYNEXIS...

error: Content is protected !!